Clinical Study Process
WELCOME TO DM CLINICAL
Your Clinical Study Journey
Apply to participate
Speak with an enrollment specialist
Interested in joining a study? Click on the button below to see all of the current studies. Must meet eligibility criteria to participate in studies.
THE MORE YOU KNOW!
Clinical Research Process
Clinical trials progress through phases, and each phase provides more information about the effectiveness and safety of the drug. The Food and Drug Administration (FDA) approves the trial at each phase before it proceeds. At Phase IV approval, the drug is then released to the general public.
This is the first time the study drug is experimented on humans for a specific indication or trial. It is tested on a smaller group, 20-100 healthy participants, with the condition/disease for multiple months to evaluate the safety and dosage of the drug.
The trial involves up to hundreds of participants with the condition/disease to test the efficacy and side effects. This usually lasts anywhere from a few months to 2 years.
Here, 300-3,000 participants who have the condition/disease are monitored for about 1-4 years to further study the drug for efficacy and adverse reactions as well as compare the effects to other treatments.
The study enrolls thousands of volunteers with the condition/disease to ensure the drug’s safety and efficacy.
FREQUENTLY ASKED QUESTIONS
Want to learn more about DM Clinical Studies? Have a question about our process? The answers to these and more can be found in our FAQ page!
Advancing medicine through innovation and dedication.